FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to clinical and laboratory diagnostics, and can be used to predict the outcome of viral pneumonia in COVID-19. The values of oxygenation, total protein and blood urea are determined. With SpO2 values less than 77.5 without oxygen support, total protein less than 55.5 g/l, blood urea more than or equal to 8.98 mMol/l, an unfavorable outcome of viral pneumonia in COVID-19 is predicted.
EFFECT: method makes it possible to improve the accuracy of predicting the outcome of viral pneumonia in COVID-19 by assessing a complex of diagnostically significant indicators: the level of oxygenation, total protein and urea in the blood.
1 cl, 1 dwg, 1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING THE OUTCOME OF VIRAL PNEUMONIA IN COVID-19 | 2021 |
|
RU2766352C1 |
| METHOD OF PREDICTING THE RISK OF DEATH IN PATIENTS WITH COVID-19 | 2023 |
|
RU2812749C1 |
| METHOD FOR PREDICTION OF OUTCOME OF VIRAL PNEUMONIA IN COVID-19 | 2021 |
|
RU2763764C1 |
| METHOD FOR PREDICTING THE EFFICIENCY OF ANTI-INFLAMMATORY THERAPY WITH GLUCOCORTICOSTEROID HORMONES IN PATIENTS WITH MODERATE COVID-19 | 2022 |
|
RU2780933C1 |
| METHOD FOR PREDICTING THE OUTCOME OF VIRAL PNEUMONIA AT COVID-19 | 2021 |
|
RU2764025C1 |
| METHOD FOR PREDICTION OF RISK OF FATAL OUTCOME IN PATIENTS WITH VARIOUS SEVERITY OF COVID-19 INFECTION | 2024 |
|
RU2820018C1 |
| METHOD FOR PREDICTION OF OUTCOME OF VIRAL PNEUMONIA IN COVID-19 | 2021 |
|
RU2763765C1 |
| METHOD OF PREDICTING THE RISK OF DEATH FROM COVID-19 IN YOUNG PATIENTS | 2023 |
|
RU2803002C1 |
| METHOD FOR PREDICTION OF THROMBOSIS AND BLEEDING IN CRITICAL PATIENTS WITH COVID-19 UNDER CONDITIONS OF ECMO | 2021 |
|
RU2766350C1 |
| METHOD FOR PREDICTING OUTCOME OF ACUTE PERIOD OF ISCHEMIC STROKE ASSOCIATED WITH COVID-19 | 2021 |
|
RU2763834C1 |
